Literature DB >> 20146643

How to diagnose cardiac amyloidosis early: impact of ECG, tissue Doppler echocardiography, and myocardial biopsy.

Cornelia Piper1, Thomas Butz, Martin Farr, Lothar Faber, Olaf Oldenburg, Dieter Horstkotte.   

Abstract

AIMS: To detect cardiac amyloidosis (CA) earlier, it is inevitable to improve diagnostic strategies. METHODS AND
RESULTS: The impact of ECG, echocardiography including tissue Doppler imaging (TDI) and strain, and myocardial biopsies was evaluated in 30 patients (63% (n = 19) men, mean age 66 +/- 8 years, NYHA 3.0 +/- 0.5, 73% with prior myocardial decompensation), in whom we proved CA. Amyloid was confirmed by apple-green birefringence under polarised light, and the causing protein by immunohistochemical examinations. Genetic analyses excluded familial CA. All patients (AL-lambda (n = 22), AL-kappa (n = 3), senile amyloidosis (n = 5)) had echocardiographic signs of restrictive cardiomyopathy (RCM), typical TDI and strain parameters (E'septal; E' lateral < 8 cm/s; E/E' > 8; S' < or =9 cm/s; global longitudinal strain (GLS) -7.9 +/- 3.8%). Pericardial effusions were present in 63% of patients. ECGs were suspicious in many patients: 19 (63%) had low-voltage, 23 (77%) reduced R waves in V(1)-V(4), and 57% both. Abnormalities, retrospectively had been present for 0.5-4 years. Twenty (67%) patients died 232 +/- 268 [2-1020] days after CA was diagnosed, but 502 +/- 333 [30-1440] days after the first symptom.
CONCLUSION: Accurate ECG evaluations, careful echocardiographic search for RCM, reduced strain/strain rates, and general indications to myocardial biopsies with correct analyses are needed to diagnose CA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20146643     DOI: 10.3109/13506121003619310

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  7 in total

Review 1.  Advances in Treatment of Cardiac Amyloid.

Authors:  Cherie N Dahm; R Frank Cornell; Daniel J Lenihan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-04-07

Review 2.  Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.

Authors:  Omar K Siddiqi; Frederick L Ruberg
Journal:  Trends Cardiovasc Med       Date:  2017-07-13       Impact factor: 6.677

3.  Cardiac amyloidosis detected on tc-99m bone scan.

Authors:  Yang Lu; John V Groth; Rajyasree Emmadi
Journal:  Nucl Med Mol Imaging       Date:  2014-12-16

4.  Cardiac amyloidosis: A new challenge of multimodality imaging.

Authors:  Carmela Nappi; Roberta Assante; Emilia Zampella; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2018-06-26       Impact factor: 5.952

Review 5.  Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.

Authors:  Wael A Aljaroudi; Milind Y Desai; W H Wilson Tang; Dermot Phelan; Manuel D Cerqueira; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2014-04       Impact factor: 5.952

6.  An unexpected mortality following cardiac surgery: a post-mortem diagnosis of cardiac amyloidosis.

Authors:  Gerard J Fitzmaurice; Victoria Wishart; Alastair N J Graham
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-10-21

7.  Multi-parametric speckle tracking analyses to characterize cardiac amyloidosis: a comparative study of systolic left ventricular longitudinal myocardial mechanics.

Authors:  Nikola Bogunovic; Martin Farr; Lukas Pirl; Cornelia Piper; Volker Rudolph; Fabian Roder
Journal:  Heart Vessels       Date:  2022-03-31       Impact factor: 1.814

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.